Works matching IS 2160763X AND DT 2021 AND VI 10
Results: 163
A Bioequivalence Study of Avanafil in Healthy Chinese Male Subjects Under Fasting and Fed Conditions: Results of a Randomized, Open‐Label, Single‐Dose, 2‐Sequence, 2‐Period Crossover Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1495, doi. 10.1002/cpdd.998
- By:
- Publication type:
- Article
An Open‐Label, Randomized, 2‐Way, Crossover Bioequivalence Study of Cefradine Capsules in Healthy Chinese Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1478, doi. 10.1002/cpdd.991
- By:
- Publication type:
- Article
Pharmacokinetics and Bioequivalence Evaluation of 2 Formulations of Tenofovir Alafenamide.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1519, doi. 10.1002/cpdd.985
- By:
- Publication type:
- Article
Effect of Varying Degrees of Hepatic Impairment on the Pharmacokinetics of Omecamtiv Mecarbil.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1442, doi. 10.1002/cpdd.969
- By:
- Publication type:
- Article
Influence of CYP2C19 Polymorphisms on the Pharmacokinetics of Omeprazole in Elderly Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1469, doi. 10.1002/cpdd.966
- By:
- Publication type:
- Article
Pharmacokinetics and Bioequivalence Study of a New Branded Generic Moxifloxacin Tablet Among Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1514, doi. 10.1002/cpdd.964
- By:
- Publication type:
- Article
First‐in‐Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Pirepemat, a Cortical Enhancer, in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1485, doi. 10.1002/cpdd.959
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1405, doi. 10.1002/cpdd.839
- Publication type:
- Article
Surveys/Research Exploring Japanese Phase I Studies in Global Drug Development: Are They Necessary Prior to Joining Global Clinical Trials?
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1410, doi. 10.1002/cpdd.1044
- By:
- Publication type:
- Article
Clinical Pharmacokinetics of Daprodustat: Results of an Absorption, Distribution, and Excretion Study With Intravenous Microtracer and Concomitant Oral Doses for Bioavailability Determination.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1419, doi. 10.1002/cpdd.1029
- By:
- Publication type:
- Article
Lack of a Clinically Meaningful Drug Interaction Between the HIV‐1 Antiretroviral Agents Islatravir, Dolutegravir, and Tenofovir Disoproxil Fumarate.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1432, doi. 10.1002/cpdd.1026
- By:
- Publication type:
- Article
Single‐ and Multiple‐Dose Pharmacokinetics and Pharmacodynamics of PN‐943, a Gastrointestinal‐Restricted Oral Peptide Antagonist of α4β7, in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 11, p. 1263, doi. 10.1002/cpdd.946
- By:
- Publication type:
- Article
Randomized, Double‐Blind, Controlled Study to Evaluate Safety and Pharmacokinetics of Single Ascending Doses of ASP5354, an Investigational Imaging Product, in Healthy Adult Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1460, doi. 10.1002/cpdd.1013
- By:
- Publication type:
- Article
Population Pharmacokinetic Model Development and Simulation for Recombinant Erwinia Asparaginase Produced in Pseudomonas fluorescens (JZP‐458).
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1503, doi. 10.1002/cpdd.1002
- By:
- Publication type:
- Article
Base and Covariate Population Pharmacokinetic Analyses of Dupilumab in Adolescents and Children ≥6 to <12 Years of Age Using Phase 3 Data.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 11, p. 1345, doi. 10.1002/cpdd.986
- By:
- Publication type:
- Article
Effects of Postoperative Day and NR1I2 on Tacrolimus Clearance in Chinese Liver Transplant Recipients—A Population Model Approach.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 11, p. 1385, doi. 10.1002/cpdd.971
- By:
- Publication type:
- Article
A Euglycemic Glucose Clamp Study to Evaluate the Bioavailability of LY2963016 Relative to Insulin Glargine in Healthy Chinese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1452, doi. 10.1002/cpdd.1014
- By:
- Publication type:
- Article
Effect of Upadacitinib on the Pharmacokinetics of Rosuvastatin or Atorvastatin in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 11, p. 1335, doi. 10.1002/cpdd.957
- By:
- Publication type:
- Article
A Phase 1 Open‐Label, Fixed‐Sequence Pharmacokinetic Drug Interaction Trial to Investigate the Effect of Cannabidiol on the CYP1A2 Probe Caffeine in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 11, p. 1279, doi. 10.1002/cpdd.950
- By:
- Publication type:
- Article
Pharmacokinetics of Ginsenoside Compound K From a Compound K Fermentation Product, CK‐30, and From Red Ginseng Extract in Healthy Korean Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 11, p. 1358, doi. 10.1002/cpdd.949
- By:
- Publication type:
- Article
Impact of Paroxetine, a Strong CYP2D6 Inhibitor, on SPN‐812 (Viloxazine Extended‐Release) Pharmacokinetics in Healthy Adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 11, p. 1365, doi. 10.1002/cpdd.948
- By:
- Publication type:
- Article
Population Pharmacokinetic Analyses of Ertugliflozin in Select Ethnic Populations.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 11, p. 1297, doi. 10.1002/cpdd.970
- By:
- Publication type:
- Article
The Pharmacokinetics of Triheptanoin and Its Metabolites in Healthy Subjects and Patients With Long‐Chain Fatty Acid Oxidation Disorders.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 11, p. 1325, doi. 10.1002/cpdd.944
- By:
- Publication type:
- Article
Mechanistic Considerations About an Unexpected Ramipril Drug‐Drug Interaction in the Development of a Triple Fixed‐Dose Combination Product Containing Ramipril, Amlodipine, and Atorvastatin.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 11, p. 1307, doi. 10.1002/cpdd.930
- By:
- Publication type:
- Article
Pharmacokinetic Interaction Among Ezetimibe, Rosuvastatin, and Telmisartan.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 11, p. 1290, doi. 10.1002/cpdd.926
- By:
- Publication type:
- Article
Pharmacokinetics of Opicapone and Its Metabolites in Healthy White and Chinese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 11, p. 1316, doi. 10.1002/cpdd.922
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 11, p. 1249, doi. 10.1002/cpdd.838
- Publication type:
- Article
Should Estimated Glomerular Filtration Rate Be Adjusted for Race?
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 11, p. 1254, doi. 10.1002/cpdd.1030
- Publication type:
- Article
Pharmacokinetics and Use‐Testing of Apalutamide Prepared in Aqueous Food Vehicles for Alternative Administration.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 11, p. 1375, doi. 10.1002/cpdd.1001
- By:
- Publication type:
- Article
Phase 1 Study Evaluating the Effects of the Proton Pump Inhibitor Rabeprazole and Food on the Pharmacokinetics of Lorlatinib in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 11, p. 1395, doi. 10.1002/cpdd.1000
- By:
- Publication type:
- Article
Pharmacokinetics and Safety of Dapoxetine Hydrochloride in Healthy Chinese Men: Impact of Dose and High‐Fat Meal.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1216, doi. 10.1002/cpdd.919
- By:
- Publication type:
- Article
Safety, Pharmacokinetics, Pharmacodynamics, and Formulation of Liver‐Distributed Farnesoid X‐Receptor Agonist TERN‐101 in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1198, doi. 10.1002/cpdd.960
- By:
- Publication type:
- Article
Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1188, doi. 10.1002/cpdd.952
- By:
- Publication type:
- Article
Evaluation of the Bioequivalence of Acarbose in Healthy Chinese People.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1225, doi. 10.1002/cpdd.921
- By:
- Publication type:
- Article
Randomized, Open‐Label, Single‐Dose, Parallel‐Group Pharmacokinetic Study of PF‐06410293 (adalimumab‐afzb), an Adalimumab Biosimilar, by Subcutaneous Dosing Using a Prefilled Syringe or a Prefilled Pen in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1166, doi. 10.1002/cpdd.939
- By:
- Publication type:
- Article
Effect of Silymarin Treatment on Circulating Bilirubin and Cardiovascular Disease Risk Factors in Healthy Men: A Single‐Blind, Randomized Crossover Trial.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1156, doi. 10.1002/cpdd.962
- By:
- Publication type:
- Article
Effect of Memantine on QT/QTc Interval in a Healthy Korean Population.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1209, doi. 10.1002/cpdd.931
- By:
- Publication type:
- Article
Evaluation of Pharmacokinetics, Safety, and Drug‐Drug Interactions of an Oral Suspension of Edaravone in Healthy Adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1174, doi. 10.1002/cpdd.925
- By:
- Publication type:
- Article
Evaluation of the Potential Effect of Iptakalim Hydrochloride on the QT Interval in Single‐ and Multiple‐Ascending‐Dose Studies Using Concentration‐QTc Analysis.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1231, doi. 10.1002/cpdd.945
- By:
- Publication type:
- Article
Safety of a Novel Weight Loss Combination Product Containing Orlistat and Acarbose.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1242, doi. 10.1002/cpdd.920
- By:
- Publication type:
- Article
Results of a Dose‐Finding Phase 1b Study of Subcutaneous Atezolizumab in Patients With Locally Advanced or Metastatic Non–Small Cell Lung Cancer.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1142, doi. 10.1002/cpdd.936
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1121, doi. 10.1002/cpdd.837
- Publication type:
- Article
Tirbanibulin: A New Topical Therapy for Actinic Keratoses With a Novel Mechanism of Action and Improved Ease of Use.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1126, doi. 10.1002/cpdd.1024
- Publication type:
- Article
Meta‐analysis of Pharmacokinetic/Pharmacodynamic Results of 3 Phase 1 Studies with Biosimilar Pegfilgrastim.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1130, doi. 10.1002/cpdd.1005
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, p. i, doi. 10.1002/cpdd.716
- Publication type:
- Article
ACCP Abstract Booklet.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, p. 1, doi. 10.1002/cpdd.1004
- Publication type:
- Article
Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Abacavir/Dolutegravir/Lamivudine Combination Tablets in Healthy Japanese Study Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 9, p. 985, doi. 10.1002/cpdd.996
- By:
- Publication type:
- Article
Apixaban Single‐Dose Pharmacokinetics, Bioavailability, Renal Clearance, and Pharmacodynamics Following Intravenous and Oral Administration.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 9, p. 974, doi. 10.1002/cpdd.990
- By:
- Publication type:
- Article
Effects of Itraconazole and Rifampin on the Pharmacokinetics of Mobocertinib (TAK‐788), an Oral Epidermal Growth Factor Receptor Inhibitor, in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 9, p. 1044, doi. 10.1002/cpdd.967
- By:
- Publication type:
- Article
Effect of GLPG1205, a GPR84 Modulator, on CYP2C9, CYP2C19, and CYP1A2 Enzymes: In Vitro and Phase 1 Studies.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 9, p. 1007, doi. 10.1002/cpdd.956
- By:
- Publication type:
- Article